Fig. 5: Neutralisation of SARS-CoV-2 strains in vitro.

Neutralisation curves of the anti-RBD nanobody trimers for a Victoria (BVIC01), b Alpha, (B1.1.7) and c Beta, (B1.351) strains of SARS-CoV-2 measured in a microneutralisation assay. Data are shown as the mean (n = 4) ± 95% CI.